Overview

Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip

Status:
Terminated

Trial end date:
2011-01-12

Target enrollment:

Participant gender:

Summary

The purpose of this study is to investigate the long-term analgesic efficacy and safety of tanezumab for patients with osteoarthritis (OA) of the knee or hip currently experiencing partial benefit from, and are tolerating, non-steroidal anti-inflammatory drug (NSAID) therapy.

Phase:

Phase 3

Details

Lead Sponsor:

Pfizer

Treatments:

Analgesics
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Celecoxib
Naproxen
Tanezumab